Enfusion, Inc.
ENFN · NYSE
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $970,899 | $881,659 | $775,999 | $827,063 |
| - Cash | $54,480 | $48,299 | $34,447 | $32,894 |
| + Debt | $20,312 | $21,128 | $17,997 | $15,460 |
| Enterprise Value | $936,731 | $854,488 | $759,549 | $809,629 |
| Revenue | $52,938 | $51,166 | $49,455 | $48,052 |
| % Growth | 3.5% | 3.5% | 2.9% | – |
| Gross Profit | $36,540 | $34,826 | $33,493 | $31,878 |
| % Margin | 69% | 68.1% | 67.7% | 66.3% |
| EBITDA | $1,584 | $5,941 | $5,576 | $1,561 |
| % Margin | 3% | 11.6% | 11.3% | 3.2% |
| Net Income | $121 | $1,415 | $1,826 | -$539 |
| % Margin | 0.2% | 2.8% | 3.7% | -1.1% |
| EPS Diluted | 0.001 | 0.015 | 0.014 | -0.006 |
| % Growth | -94.1% | 7% | 336.7% | – |
| Operating Cash Flow | $9,673 | $16,162 | $7,314 | $1,533 |
| Capital Expenditures | -$2,663 | -$2,775 | -$2,706 | -$2,748 |
| Free Cash Flow | $7,010 | $13,387 | $4,608 | -$1,215 |